Pharmacokinetics and pharmacodynamics of escalating doses of single-dose or multiple-dose ONO 5334 in Caucasian women with postmenopausal osteoporosis
Latest Information Update: 29 Mar 2014
At a glance
- Drugs ONO 5334 (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 29 Mar 2014 New trial record
- 01 Mar 2014 Pooled population pharmacokinetic /pharmacodynamic analysis published in the Journal of Clinical Pharmacology.